These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3291101)

  • 21. [AIDS: what have we learned from earlier epidemics? Comparison with widespread pestilence--search for scapegoats].
    Arnheim K
    Fortschr Med; 1992 Dec; 110(35-36):16-7. PubMed ID: 1487221
    [No Abstract]   [Full Text] [Related]  

  • 22. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 24. Understanding the costs of pharmaceuticals.
    Valenti WM
    AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597
    [No Abstract]   [Full Text] [Related]  

  • 25. Bush declines to support drug companies' line on AIDS profits.
    Dickson D
    Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
    [No Abstract]   [Full Text] [Related]  

  • 26. Steering a course to an AIDS vaccine.
    Baltimore D
    Science; 2002 Jun; 296(5577):2297. PubMed ID: 12089410
    [No Abstract]   [Full Text] [Related]  

  • 27. How to combat the AIDS--and FRAIDS--epidemics.
    Fisher EJ
    Mich Med; 1986 Mar; 85(3):93-5. PubMed ID: 3959921
    [No Abstract]   [Full Text] [Related]  

  • 28. A tragic and lucrative growth industry.
    Bateman C
    S Afr Med J; 2002 Jan; 92(1):17-8. PubMed ID: 11936003
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drugs and the market].
    Tognoni G
    Assist Inferm Ric; 2008; 27(4):226-9. PubMed ID: 19260373
    [No Abstract]   [Full Text] [Related]  

  • 30. South Africa cuts agreement for one AIDS drug but ignores another.
    IAPAC Mon; 2001 Feb; 7(2):41. PubMed ID: 11302027
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS and the private sector.
    Nature; 2006 Oct; 443(7113):723. PubMed ID: 17051166
    [No Abstract]   [Full Text] [Related]  

  • 32. Twenty-five years of AIDS.
    Cameron DW
    CMAJ; 2006 Aug; 175(3):225, 227. PubMed ID: 16880433
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activists and researchers rally behind AIDS drug for mothers.
    Check E
    Nature; 2004 Dec; 432(7020):935. PubMed ID: 15616517
    [No Abstract]   [Full Text] [Related]  

  • 35. Global AIDS trial denied patients as US balks at generic drug use.
    Check E
    Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug companies seek trial participants.
    AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS meeting urged to rethink prevention strategy.
    Check E
    Nature; 2006 Aug; 442(7104):724-5. PubMed ID: 16915248
    [No Abstract]   [Full Text] [Related]  

  • 38. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 39. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 40. Faculty demands AIDS drugs for all.
    Novak K
    Nat Med; 2002 Jan; 8(1):6-7. PubMed ID: 11786883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.